These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic overview of oral second-generation H1 antihistamines. González MA; Estes KS Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995 [TBL] [Abstract][Full Text] [Related]
7. Evolution of H1-receptor antagonist treatment. Simons FE Ann Allergy; 1993 Sep; 71(3):282-7. PubMed ID: 8103973 [TBL] [Abstract][Full Text] [Related]
8. New oral H1 antihistamines in children: facts and unmeet needs. de Benedictis FM; de Benedictis D; Canonica GW Allergy; 2008 Oct; 63(10):1395-404. PubMed ID: 18782118 [TBL] [Abstract][Full Text] [Related]
9. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093 [TBL] [Abstract][Full Text] [Related]
10. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555 [TBL] [Abstract][Full Text] [Related]